🇺🇸 lansoprazole OD in United States
318 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 318
Most-reported reactions
- Pyrexia — 55 reports (17.3%)
- Interstitial Lung Disease — 50 reports (15.72%)
- Decreased Appetite — 36 reports (11.32%)
- Diarrhoea — 35 reports (11.01%)
- Pneumonia — 32 reports (10.06%)
- Hepatic Function Abnormal — 25 reports (7.86%)
- Vomiting — 24 reports (7.55%)
- Malignant Neoplasm Progression — 22 reports (6.92%)
- Cerebral Infarction — 20 reports (6.29%)
- Nausea — 19 reports (5.97%)
Other Gastroenterology approved in United States
Frequently asked questions
Is lansoprazole OD approved in United States?
lansoprazole OD does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for lansoprazole OD in United States?
Far Eastern Memorial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.